Table 8 ILCR values of average dermal dose.
PAHs | \({\mathrm{ILCR}}_{\mathrm{Dermal}}\) (ADULT) | \({\mathrm{ILCR}}_{\mathrm{Dermal}}\) (CHILD) | ||
|---|---|---|---|---|
Study sample | Control sample | Study sample | Control sample | |
BbF | 7.61 \(\times {10}^{-5}\) | 7.46 \(\times {10}^{-5}\) | 3.0 \(\times {10}^{-5}\) | 2.34 \(\times {10}^{-5}\) |
BaA | 2.75 \(\times {10}^{-5}\) | 8.22 \(\times {10}^{-6}\) | 2.97 \(\times {10}^{-6}\) | 2.2 \(\times {10}^{-6}\) |
BaP | 2.81 \(\times {10}^{-5}\) | 1.83 \(\times {10}^{-5}\) | 1.11 \(\times {10}^{-5}\) | 7.22 \(\times {10}^{-6}\) |
DBahA | 7.85 \(\times {10}^{-5}\) | – | 3.1 \(\times {10}^{-6}\) | – |
HI | 1.39 \(\times {10}^{-4}\) | 1.01 \(\times {10}^{-4}\) | 4.71 \(\times {10}^{-5}\) | 3.28 \(\times {10}^{-5}\) |
